Nitrofurantoin Treatment for Uncomplicated Urinary Tract Infections
For uncomplicated urinary tract infections in women, nitrofurantoin monohydrate/macrocrystals should be prescribed at a dose of 100 mg twice daily for 5 days. 1, 2
First-Line Treatment Recommendation
- Nitrofurantoin monohydrate/macrocrystals is a first-line agent for uncomplicated UTIs due to its high efficacy, minimal resistance patterns, and limited propensity for collateral damage (ecological adverse effects) 1, 2
- The 5-day regimen is recommended by both the Infectious Diseases Society of America (IDSA) and the European Society for Microbiology and Infectious Diseases (ESMID) 3, 1
- Clinical cure rates with nitrofurantoin range from 88-93% for uncomplicated UTIs in women 1
- Bacterial cure rates range from 81-92% for uncomplicated UTIs 1
Efficacy Evidence
- Nitrofurantoin has demonstrated significantly better bacteriological cure rates compared to placebo (21/26 vs. 5/25) after just 3 days of treatment 4
- The 5-day regimen of nitrofurantoin monohydrate/macrocrystals (100 mg twice daily) has been shown to be equivalent to trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) in clinical and microbiological cure rates 1
- Despite its long history of use (over 60 years), nitrofurantoin has maintained good activity against common uropathogens including Escherichia coli, Staphylococcus saprophyticus, and Enterococcus species 5
Important Contraindications and Precautions
- Nitrofurantoin is contraindicated in patients with:
- While some evidence suggests nitrofurantoin may be effective in patients with moderate renal insufficiency (CrCl 30-60 ml/min), current guidelines still recommend avoiding it in patients with any degree of renal impairment 6
- Avoid nitrofurantoin if early pyelonephritis is suspected 3
Common Side Effects
- Most common adverse effects include nausea and headache 1
- Adverse event rates range from 5.6-34% across studies 1
- Serious side effects such as pulmonary reactions and polyneuropathy are primarily associated with long-term use rather than short-course therapy 5
Treatment Duration Considerations
- While some UK guidelines have suggested 3-day courses, the strongest evidence supports a 5-day regimen 7, 1
- The IDSA and European guidelines consistently recommend 5 days as the optimal duration 3, 1, 2
- Shorter courses may lead to treatment failure, while longer courses increase the risk of adverse effects without additional benefit 1, 2
Alternative First-Line Options When Nitrofurantoin Cannot Be Used
- Fosfomycin trometamol 3 g single dose (note: slightly lower efficacy than nitrofurantoin) 3, 2
- Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (only if local resistance rates <20% or if the infecting strain is confirmed susceptible) 3, 2
- Pivmecillinam 400 mg twice daily for 5 days (where available) 3, 2
Follow-up Recommendations
- Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 2
- For women whose symptoms do not resolve by the end of treatment or recur within 2 weeks, a urine culture with susceptibility testing should be performed 2
- Consider retreatment with a 7-day regimen using another agent if symptoms persist or recur 2